Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 136th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
LTGO	LATIGO BIOTHERAPEUTICS INC	$1.20B	N/A	N/A	N/A	N/A	-0.19	1.15	N/A	N/A	N/A
RCUS	ARCUS BIOSCIENCES INC	$3.27B	-89.50%	-45.60%	-61.85%	-65.40%	0.99	3.82	100.00%	-393.20%	-383.76%
ANIX	ANIXA BIOSCIENCES INC	$99.08M	-70.20%	-67.80%	-77.89%	-83.20%	0.13	8.55	N/A	N/A	N/A
AVIR	ATEA PHARMACEUTICALS INC	$415.46M	-64.20%	-57.10%	-84.14%	-96.80%	0.14	8.13	N/A	N/A	N/A
NRIX	NURIX THERAPEUTICS INC	$2.46B	-76.10%	-57.30%	-73.70%	-75.50%	0.33	6.34	100.00%	-928.40%	-929.18%
BOLD	BOUNDLESS BIO INC	$58.23M	-70.90%	-47.40%	-97.02%	-44.60%	0.12	9.48	N/A	N/A	N/A
IRON	DISC MEDICINE INC	$2.53B	-37.20%	-33.70%	-34.34%	-38.20%	0.14	24.14	N/A	N/A	N/A
NXTC	NEXTCURE INC	$22.18M	-175.50%	-113.70%	-263.76%	-252.10%	0.86	3.47	N/A	N/A	N/A
IMTX	IMMATICS NV	$1.17B	-47.00%	-39.20%	-48.22%	-112.80%	0.22	7.54	100.00%	-495.30%	-495.79%
MNPR	MONOPAR THERAPEUTICS	$536.97M	-13.10%	-12.80%	-13.63%	-28.40%	0.03	33.56	N/A	N/A	N/A
OBX	OBSIDIAN THERAPEUTICS INC	$900.65M	N/A	N/A	N/A	N/A	-0.07	2.30	N/A	N/A	N/A
DNLI	DENALI THERAPEUTICS INC	$3.33B	-55.30%	-44.20%	-47.88%	-53.60%	0.39	8.37	97.40%	-14,191.20%	-14,188.37%
VANI	VIVANI MEDICAL INC	$110.95M	-191.10%	-70.90%	-75.22%	-84.50%	1.20	3.25	N/A	N/A	N/A
PEPG	PEPGEN INC	$162.07M	-51.00%	-43.50%	-54.28%	-69.90%	0.18	13.36	N/A	N/A	N/A
TRDA	ENTRADA THERAPEUTICS INC	$243.74M	-57.60%	-46.50%	-59.44%	-56.60%	0.28	10.89	100.00%	-3,537.70%	-3,520.25%
BRVE	BRAVEHEART BIO INC	$2.01B	N/A	N/A	N/A	N/A	-0.10	13.63	N/A	N/A	N/A
BIVI	BIOVIE INC	$11.62M	-126.30%	-109.10%	-210.96%	-2,942.30%	0.39	3.59	N/A	N/A	N/A
SPTX	SEAPORT THERAPEUTICS INC	$1.00B	N/A	N/A	N/A	N/A	0.05	18.00	N/A	N/A	N/A
IPSC	CENTURY THERAPEUTICS INC	$298.77M	-52.80%	-40.60%	-40.40%	-54.50%	0.24	8.28	N/A	N/A	N/A
IMUX	IMMUNIC INC	$121.57M	-157.90%	-107.90%	-87.22%	412.10%	0.25	5.05	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$660.52M	-31.80%	-30.80%	-23.97%	-37.40%	0.03	31.45	N/A	N/A	N/A
OCGN	OCUGEN INC	$369.63M	N/A	-116.00%	826.79%	-333.10%	-8.50	0.80	100.00%	-1,786.30%	-1,601.94%
GHRS	GH RESEARCH PLC	$1.69B	-20.90%	-20.10%	-17.24%	-220.00%	0.04	28.70	N/A	N/A	N/A
PLRX	PLIANT THERAPEUTICS INC	$66.88M	-53.20%	-41.30%	-52.68%	-46.40%	0.29	9.90	N/A	N/A	N/A
ICU	SEASTAR MEDICAL HOLDING CORP	$15.69M	-162.80%	-109.90%	-316.50%	718.60%	1.01	1.89	92.60%	-795.50%	-793.75%
VSTM	VERASTEM INC	$717.26M	-467.50%	-94.50%	-156.10%	-369.60%	3.13	2.26	86.40%	-231.60%	-228.97%
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$389.40M	-46.50%	-36.50%	-48.90%	-375.40%	0.31	5.88	100.00%	-317.60%	-317.64%
LYEL	LYELL IMMUNOPHARMA INC	$235.98M	-91.60%	-70.50%	-91.59%	-93.70%	0.33	5.36	100.00%	-993,908.00%	-993,908.00%
GNPX	GENPREX INC	$2.34M	-163.10%	-129.00%	-111.51%	4,732.10%	0.16	6.77	N/A	N/A	N/A
ZLAB	ZAI LAB LTD	$2.91B	-27.40%	-16.70%	-28.59%	-155.70%	0.77	2.13	56.50%	-41.90%	-41.09%
NUVB	NUVATION BIO INC	$1.97B	-49.70%	-23.50%	-18.72%	-19.00%	1.93	8.37	88.20%	-88.20%	-72.49%
VBIO	VALION BIO INC	$2.51M	-199.00%	-69.10%	-58.67%	-71.20%	4.85	1.11	66.70%	12,019.20%	11,067.31%
NAMS	NEWAMSTERDAM PHARMA CO NV	$2.85B	-38.30%	-34.70%	-41.09%	-131.10%	0.12	9.03	100.00%	-3,644.20%	-3,644.21%
DMRA	DAMORA THERAPEUTICS INC	$1.28B	-82.40%	-77.90%	-50.86%	1,686.80%	0.05	19.73	N/A	N/A	N/A
PALI	PALISADE BIO INC	$252.69M	-33.50%	-31.80%	-26.16%	956.50%	0.05	24.26	100.00%	-6,388.20%	-6,386.60%
BLSM	BLOSSOMHILL THERAPEUTICS INC	$679.24M	N/A	N/A	N/A	N/A	-0.24	5.42	N/A	N/A	N/A
TRAX	FIRST TRACKS BIOTHERAPEUTICS INC	$1.29B	N/A	N/A	N/A	N/A	0.09	14.28	N/A	N/A	N/A
EWTX	EDGEWISE THERAPEUTICS INC	$4.26B	-39.00%	-37.00%	-43.76%	-43.00%	0.07	16.24	N/A	N/A	N/A
GYRE	GYRE THERAPEUTICS INC	$816.25M	-17.70%	-10.80%	-8.18%	-12.90%	0.32	4.26	94.30%	-15.50%	-11.69%
VTVT	VTV THERAPEUTICS INC	$118.62M	-6.30%	-5.10%	-5.90%	71.10%	0.11	12.48	100.00%	-12.90%	-12.89%
ACRV	ACRIVON THERAPEUTICS INC	$89.13M	-70.10%	-61.60%	-84.69%	-103.80%	0.14	7.99	N/A	N/A	N/A
CYTK	CYTOKINETICS INC	$9.13B	N/A	-59.00%	-48.14%	-34.80%	-12.09	6.66	88.00%	-1,321.10%	-1,240.14%
NNVC	NANOVIRICIDES INC	$33.18M	-91.10%	-80.70%	-94.65%	-145.80%	0.14	2.66	N/A	N/A	N/A
CBUS	CIBUS INC	$118.46M	-320.60%	-30.90%	-20.45%	-21.10%	20.18	1.62	100.00%	-2,258.90%	-1,406.69%
SVRA	SAVARA INC	$1.04B	-90.30%	-69.00%	-79.82%	-76.60%	0.34	10.13	N/A	N/A	N/A
SGP	SPYGLASS PHARMA INC	$850.92M	N/A	N/A	N/A	N/A	0.05	25.06	N/A	N/A	N/A
PLRZ	POLYRIZON LTD	$22.30M	-21.40%	-21.00%	-21.25%	-77.10%	0.02	36.37	N/A	N/A	N/A
ENTA	ENANTA PHARMACEUTICALS INC	$368.15M	-61.80%	-20.70%	-20.69%	-18.00%	1.94	3.76	100.00%	-96.90%	-76.95%
FTH	FAETH THERAPEUTICS INC	$725.34M	-1,012.20%	-175.70%	-108.79%	-356.40%	0.06	19.69	N/A	N/A	N/A
BMEA	BIOMEA FUSION INC	$91.33M	-171.20%	-66.10%	-123.30%	583.90%	2.04	3.48	N/A	N/A	N/A
AVLN	AVALYN PHARMA INC	$1.20B	N/A	N/A	N/A	N/A	0.07	33.12	N/A	N/A	N/A
CGTX	COGNITION THERAPEUTICS INC	$90.72M	-50.20%	-40.20%	-50.12%	1,019.40%	0.18	7.03	N/A	N/A	N/A
PDSB	PDS BIOTECHNOLOGY CORP	$41.59M	-708.20%	-136.50%	779.57%	-393.60%	-3.46	0.57	N/A	N/A	N/A
CRBU	CARIBOU BIOSCIENCES INC	$132.94M	-89.10%	-62.50%	-83.30%	-67.60%	0.46	6.49	100.00%	-1,684.40%	-1,693.32%
DMAC	DIAMEDICA THERAPEUTICS INC	$442.19M	-77.80%	-69.50%	-97.80%	-90.80%	0.17	6.72	N/A	N/A	N/A
ODTX	ODYSSEY THERAPEUTICS INC	$1.08B	N/A	N/A	N/A	N/A	0.15	11.36	N/A	N/A	N/A
GLUE	MONTE ROSA THERAPEUTICS INC	$1.00B	-43.30%	-27.60%	-25.97%	-40.30%	0.42	10.58	100.00%	-560.90%	-570.80%
IONS	IONIS PHARMACEUTICALS INC	$7.63B	-110.90%	-17.40%	-17.64%	-11.60%	5.81	7.89	98.20%	-64.70%	-54.06%
GLSI	GREENWICH LIFESCIENCES INC	$269.79M	-793.80%	-295.30%	-695.56%	470.30%	1.85	1.54	N/A	N/A	N/A
KLRS	KALARIS THERAPEUTICS INC	$69.03M	-71.70%	-42.90%	-48.75%	-107.00%	0.73	10.98	N/A	N/A	N/A
TTRX	TURN THERAPEUTICS INC	$399.46M	-281.60%	-64.90%	-100.10%	-372.50%	23.69	1.19	N/A	N/A	N/A
ELAB	PMGC HOLDINGS INC	$2.97M	-118.10%	-59.70%	-57.22%	-304.60%	1.19	1.36	31.10%	-523.00%	-471.21%
PTHS	PELTHOS THERAPEUTICS INC	$80.09M	-264.30%	-64.00%	-81.95%	-135.70%	-92.51	1.98	78.60%	-199.50%	-199.47%
DTIL	PRECISION BIOSCIENCES INC	$170.58M	-91.60%	-40.70%	-43.28%	-144.40%	1.78	12.82	100.00%	-117.00%	-114.11%
FLNA	FILANA THERAPEUTICS INC	$44.68M	-58.80%	-36.70%	-66.33%	204.70%	0.63	2.09	N/A	N/A	N/A
MNKD	MANNKIND CORP	$1.07B	N/A	-6.30%	-0.03%	0.00%	-11.90	1.72	75.40%	-11.10%	-0.05%
GANX	GAIN THERAPEUTICS INC	$73.32M	-161.60%	-118.40%	-160.16%	1,956.40%	0.37	4.36	N/A	N/A	N/A
MIRM	MIRUM PHARMACEUTICALS INC	$5.68B	-410.20%	-96.50%	-102.66%	-154.60%	-101.27	2.86	81.70%	-139.20%	-136.57%
PMN	PROMIS NEUROSCIENCES INC	$95.37M	-143.10%	-109.20%	-85.35%	825.20%	0.15	7.86	N/A	N/A	N/A
CLNN	CLENE INC	$52.68M	N/A	-185.60%	-201.42%	-129.80%	-1.93	3.07	70.10%	-20,059.90%	-18,597.46%
AVTX	AVALO THERAPEUTICS INC	$835.56M	-58.00%	-48.20%	-21.33%	-68.70%	0.09	19.31	100.00%	-170,055.90%	-169,766.10%
OTLK	OUTLOOK THERAPEUTICS INC	$152.40M	N/A	-288.00%	2,502.35%	43,243.80%	-3.52	0.81	195.60%	5,253.50%	5,364.40%
ELVN	ENLIVEN THERAPEUTICS INC	$3.41B	-18.50%	-18.10%	-11.82%	-23.30%	0.02	64.07	N/A	N/A	N/A
HURA	TUHURA BIOSCIENCES INC	$131.91M	-154.30%	-107.00%	-131.17%	-328.20%	0.72	0.18	N/A	N/A	N/A
BDTX	BLACK DIAMOND THERAPEUTICS INC	$107.44M	-38.80%	-30.50%	-38.97%	-37.80%	0.30	7.28	N/A	N/A	N/A
BSEM	BIOSTEM TECHNOLOGIES INC	$68.36M	N/A	N/A	N/A	N/A	0.77	0.98	N/A	N/A	N/A
DBVT	DBV TECHNOLOGIES SA	$683.90M	-119.30%	-84.40%	-103.74%	3,499.70%	0.39	3.72	100.00%	-3,506.50%	-3,491.11%
COYA	COYA THERAPEUTICS INC	$117.99M	-53.30%	-47.50%	-49.47%	3,005.10%	0.09	13.40	100.00%	-270.20%	-270.19%
EIKN	EIKON THERAPEUTICS INC	$428.45M	N/A	N/A	N/A	N/A	0.67	9.89	N/A	N/A	N/A
QSI	QUANTUM-SI INC	$209.69M	-47.10%	-43.20%	-54.29%	-52.70%	0.07	9.97	35.00%	-6,138.30%	-6,144.17%
ZBIO	ZENAS BIOPHARMA INC	$1.74B	-189.70%	-89.90%	-72.33%	-118.20%	1.84	9.93	100.00%	-48,438.40%	-45,990.40%
AARD	AARDVARK THERAPEUTICS INC	$117.08M	-71.50%	-64.90%	-93.09%	-163.90%	0.09	12.63	N/A	N/A	N/A
IDYA	IDEAYA BIOSCIENCES INC	$3.65B	-16.50%	-15.10%	-14.26%	-19.30%	0.09	10.45	100.00%	-74.80%	-74.75%
PMVP	PMV PHARMACEUTICALS INC	$76.45M	-78.10%	-70.10%	-105.17%	-114.60%	0.15	7.70	N/A	N/A	N/A
TRVI	TREVI THERAPEUTICS INC	$2.05B	-23.60%	-22.60%	-15.90%	-28.40%	0.03	37.28	N/A	N/A	N/A
ATTO	ATTOVIA THERAPEUTICS INC	$829.03M	N/A	N/A	N/A	N/A	-0.11	9.39	N/A	N/A	N/A
AKTX	AKARI THERAPEUTICS PLC	$0.00	-147.40%	-74.70%	-128.95%	259.70%	1.08	0.60	N/A	N/A	N/A
RAPP	RAPPORT THERAPEUTICS INC	$1.58B	-29.00%	-27.40%	-31.86%	-36.00%	0.09	15.72	100.00%	-685.80%	-685.80%
CLDI	CALIDI BIOTHERAPEUTICS INC	$2.79M	-500.50%	-236.40%	-436.10%	-1,006.70%	1.30	1.68	N/A	N/A	N/A
LGVN	LONGEVERON INC	$8.67M	-223.20%	-150.20%	-209.96%	-12,453.10%	0.49	2.63	69.80%	-1,977.60%	-1,977.59%
AKTS	AKTIS ONCOLOGY INC	$1.10B	N/A	N/A	N/A	N/A	0.15	16.33	N/A	N/A	N/A
DFTX	DEFINIUM THERAPEUTICS INC	$5.13B	-85.20%	-64.60%	-36.49%	-198.20%	0.21	6.95	N/A	N/A	N/A
KRRO	KORRO BIO INC	$140.78M	-114.30%	-68.60%	-70.15%	-69.50%	0.58	9.55	100.00%	-4,477.10%	-4,441.86%
LABT	LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC	$2.35M	N/A	-443.70%	-166.77%	-29,672.30%	0.15	7.70	N/A	N/A	N/A
ERAS	ERASCA INC	$4.97B	-80.40%	-67.10%	-71.54%	-74.30%	0.20	8.29	N/A	N/A	N/A
ANRO	ALTO NEUROSCIENCE INC	$1.04B	-46.50%	-39.10%	-34.53%	-404.10%	0.16	14.85	N/A	N/A	N/A
EQ	EQUILLIUM INC	$102.72M	-41.20%	-38.30%	-32.05%	2,525.80%	0.05	23.40	N/A	N/A	N/A
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$365.44M	-151.00%	-54.70%	-53.96%	-53.20%	4.47	8.26	99.50%	-186.30%	-172.51%
CRVO	CERVOMED INC	$43.54M	-156.00%	-128.30%	-132.18%	-408.30%	0.13	8.57	100.00%	-9,160.90%	-9,160.94%
MBX	MBX BIOSCIENCES INC	$2.78B	-26.00%	-24.90%	-25.30%	-34.30%	0.06	18.08	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Sep 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: B, Growth: C, Momentum: A, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 48, which is 24 points higher than the biotech industry average of 24.

PBYI passed 15 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 93.66% over the past year, overperforming other biotech stocks by 167 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -38.65% from Puma Biotechnology's current stock price of $9.78.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Precigen (NASDAQ:PGEN)

Precigen (NASDAQ:PGEN) is the #2 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Precigen (NASDAQ:PGEN) is: Value: C, Growth: A, Momentum: A, Sentiment: B, Safety: F, Financials: C, and AI: B.

Precigen (NASDAQ:PGEN) has a Due Diligence Score of 29, which is 5 points higher than the biotech industry average of 24.

PGEN passed 10 out of 33 due diligence checks and has average fundamentals. Precigen has seen its stock return 121.76% over the past year, overperforming other biotech stocks by 195 percentage points.

Precigen has an average 1 year price target of $13.67, an upside of 69.78% from Precigen's current stock price of $8.05.

Precigen stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Precigen, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Beone Medicines (NASDAQ:ONC)

Beone Medicines (NASDAQ:ONC) is the #3 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 28, which is 4 points higher than the biotech industry average of 24.

ONC passed 9 out of 33 due diligence checks and has average fundamentals. Beone Medicines has seen its stock return 9.75% over the past year, overperforming other biotech stocks by 83 percentage points.

Beone Medicines has an average 1 year price target of $418.55, an upside of 14.59% from Beone Medicines's current stock price of $365.27.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Beone Medicines, 81.82% have issued a Strong Buy rating, 18.18% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.33%, which is 3 percentage points higher than the biotech industry average of 2.12%.

Oramed Pharmaceuticals's dividend payout ratio of 5.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 4.84%, which is 3 percentage points higher than the biotech industry average of 2.12%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 46.1% indicates that its high dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.59%, which is -1 percentage points lower than the biotech industry average of 2.12%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 48.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.59% in the last day, and down -3.09% over the last week. Stablecoin Development was the among the top gainers in the biotechnology industry, gaining 108.28% yesterday.

Stablecoin Development shares are trading lower. The company announced it is aware of unusual trading activity and that there has been no material development in its business and affairs.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 42.15% in the past year. It has overperformed other stocks in the biotech industry by 115 percentage points.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 80.09% in the past year. It has overperformed other stocks in the biotech industry by 153 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Exelixis's stock has gained 44.56% in the past year. It has overperformed other stocks in the biotech industry by 118 percentage points.

Are biotech stocks a good buy now?

64.68% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 63.92% over the next year.

3.04% of biotech stocks have a Zen Rating of A (Strong Buy), 3.69% of biotech stocks are rated B (Buy), 44.9% are rated C (Hold), 36.88% are rated D (Sell), and 11.5% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 9.98x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Precigen (NASDAQ:PGEN)

3. Beone Medicines (NASDAQ:ONC)

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Precigen (NASDAQ:PGEN)

3. Beone Medicines (NASDAQ:ONC)

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.